00 mg/mL Concentrate for solution for infusion, VHB937
CVHB937A12201
Phase 2 small_molecule active
Quick answer
00 mg/mL Concentrate for solution for infusion, VHB937 for Alzheimer’s disease is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Alzheimer’s disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active